Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
AVNR [NASD]
Avanir Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.31 Insider Own0.50% Shs Outstand193.76M Perf Week-0.59%
Market Cap3.26B Forward P/E- EPS next Y-0.20 Insider Trans64.82% Shs Float190.74M Perf Month24.17%
Income-50.40M PEG- EPS next Q-0.06 Inst Own83.60% Short Float7.25% Perf Quarter50.31%
Sales115.00M P/S28.39 EPS this Y41.50% Inst Trans27.56% Short Ratio2.14 Perf Half Y214.37%
Book/sh1.59 P/B10.60 EPS next Y48.70% ROA-35.30% Target Price16.86 Perf Year487.11%
Cash/sh1.40 P/C12.01 EPS next 5Y19.20% ROE-53.50% 52W Range2.94 - 17.05 Perf YTD401.49%
Dividend- P/FCF- EPS past 5Y-2.10% ROI-17.30% 52W High-0.70% Beta0.92
Dividend %- Quick Ratio9.30 Sales past 5Y93.90% Gross Margin97.00% 52W Low475.85% ATR0.28
Employees- Current Ratio9.40 Sales Q/Q50.70% Oper. Margin-40.30% RSI (14)80.27 Volatility0.52% 1.52%
OptionableYes Debt/Eq0.00 EPS Q/Q66.70% Profit Margin-43.80% Rel Volume0.72 Prev Close16.85
ShortableYes LT Debt/Eq0.00 EarningsDec 15 AMC Payout- Avg Volume6.47M Price16.93
Recom2.50 SMA204.18% SMA5020.81% SMA200115.46% Volume1,249,464 Change0.47%
Dec-03-14Downgrade Mizuho Buy → Neutral $17
May-02-14Upgrade Mizuho Neutral → Buy $5 → $10
Dec-11-13Downgrade Mizuho Buy → Neutral $11 → $5
Jul-12-13Reiterated Mizuho Buy $10 → $11
Jul-08-13Reiterated Summer Street Research Buy $14 → $16
Jun-14-13Initiated Mizuho Buy $10
Aug-23-11Initiated JMP Securities Mkt Outperform $7
Nov-02-10Reiterated Wedbush Outperform $9 → $13
Oct-07-10Reiterated Canaccord Genuity Buy $6 → $9
Jul-01-10Initiated Jefferies Buy $10
Apr-29-10Initiated Wedbush Outperform $9
Apr-06-10Initiated Canaccord Adams Buy $6
Apr-06-10Initiated Canaccord Adams Buy
Jan-29-10Initiated Merriman Buy
Mar-01-07Reiterated Punk, Ziegel & Co Sell $2 → $1.25
Feb-27-07Upgrade Wedbush Morgan Sell → Hold $1.50
Dec-17-14 01:04PM  AVANIR PHARMACEUTICALS, INC. Financials EDGAR Online Financials
Dec-12-14 07:07PM  10-K for Avanir Pharmaceuticals, Inc. Company Spotlight
Dec-11-14 10:12AM  Morgan & Morgan Announces That Class Action Lawsuits Have Been Filed in Connection With the Sale of Avanir Pharmaceuticals, Inc. -- AVNR GlobeNewswire
Dec-10-14 06:48PM  Avanir reports 4Q loss AP
05:30PM  AVANIR PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report EDGAR Online
Dec-09-14 08:30AM  Through Laughter and Tears Comes First-Ever Documentary about Life with PseudoBulbar Affect (PBA) PR Newswire
Dec-08-14 09:11AM  Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire
07:51AM  The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, Cypress Semiconductor, Spansion and Automatic Data Processing Zacks
Dec-05-14 04:01PM  Avanir Pharmaceuticals Cancels Previously Scheduled Earnings Call PR Newswire
Dec-04-14 03:19PM  Lifshitz & Miller Law Firm Announces Investigation of Avanir Pharmaceuticals, Inc., Carbonite, Inc., Casey's General Stores, Inc., Nymox Pharmaceutical Corporation, Puma Biotechnology Inc., RealD Inc., and Spansion, Inc. PR Newswire
11:57AM  AVNR INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Avanir Pharmaceuticals, Inc. in Connection With the Fairness of the Sale of the Company to Otsuka Pharmaceutical Co., Ltd. -- AVNR PR Newswire
11:39AM  AVANIR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Business Wire
11:30AM  Wolf Popper LLP Investigates Claims That the Proposed Acquisition of Avanir Pharmaceuticals, Inc. May Not Be In the Best Interests of Its Investors PR Newswire
10:33AM  Avanir Pharmaceuticals Inc. Stockholders Encouraged to Contact Securities Law Firm about Takeover PR Newswire
Dec-03-14 08:35PM  SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Avanir Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information Business Wire
07:30PM  AVANIR PHARMACEUTICALS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Avanir Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Otsuka Pharmaceutical Co., Ltd. - AVNR PR Newswire
03:35PM  UPDATE: Deutsche Bank Downgrades Avanir Pharmaceuticals, $17 Buyout Target 'Fair' Benzinga
02:30PM  Avanir to be acquired by Otsuka for $3.5 Billion, Shares Up Zacks
10:33AM  Ryan & Maniskas, LLP Announces Investigation of Avanir Pharmaceuticals, Inc. PR Newswire
07:25AM  Avanir Pharmaceuticals, Inc. (AVNR) in Focus: Stock Soars 12.8% Zacks
05:31AM  Avanir Pharmaceuticals downgraded by Mizuho Briefing.com
12:01AM  Skadden and Latham on Otsuka-Avanir Deal: Business of Law at Bloomberg
Dec-02-14 10:35PM  SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Avanir Pharmaceuticals, Inc. in Connection with the Sale of the Company -AVNR PR Newswire +12.80%
08:39PM  Japanese firm Otsuka to buy Avanir Pharmaceuticals for $3.5 billion at Los Angeles Times
08:00PM  Harwood Feffer LLP Announces Investigation of Avanir Pharmaceuticals, Inc. PR Newswire
07:27PM  Acquisition of Avanir Pharmaceuticals, Inc. (AVNR) by Otsuka Pharmaceutical Co., Ltd. May Not Be in Shareholders' Best Interests PR Newswire
06:33PM  Cramer's heated love affair with biotech at CNBC
04:08PM  Energy companies lead an advance in US stocks AP
03:32PM  Stocks head higher, bouncing back from day before AP
03:02PM  US STOCKS-Energy shares lead Wall St higher in broad advance Reuters
02:28PM  Japanese firm to buy Avanir Pharmaceuticals for $3.5 billion at Los Angeles Times
12:31PM  Japan's Otsuka to buy Avanir for $3.5 bln ahead of patent cliff Reuters
12:24PM  AVANIR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Otsuka Pharmaceutical Co., Ltd. Business Wire
12:09PM  Abilify Maker Otsuka to Buy Avanir at The Wall Street Journal
11:56AM  Stocks move higher, rebounding from the day before AP
11:37AM  EQUITY ALERT: The Rosen Law Firm Announces Investigation of Avanir Pharmaceuticals Concerning its Proposed Sale to Otsuka Pharmaceutical AVNR Business Wire
11:22AM  Avanir Stock Jumps On $3.5 Billion Otsuka Buyout at Investor's Business Daily
10:49AM  Block & Leviton LLP Investigates Avanir Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duty in Connection with Their Proposed Acquisition by Otsuka Pharmaceutical Co., Ltd. PR Newswire
10:35AM  AVNR INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Avanir Pharmaceuticals, Inc. in Connection With the Fairness of the Sale of the Company to Otsuka Pharmaceutical Co., Ltd. -- AVNR Business Wire
10:32AM  AVANIR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout PR Newswire
10:26AM  Mid-Morning Market Update: Markets Open Higher; Cypress To Acquire Spansion In $4 Billion Deal Benzinga
09:39AM  Story Stocks from Briefing.com Briefing.com
09:22AM  Wal-Mart breaks online sales record; Apple heads to court; Royal Caribbean to join S&P 500 Hot Stock Minute
09:16AM  AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or P EDGAR Online
09:15AM  Are Avanir Shareholders Getting Enough in the Buyout? at 24/7 Wall St.
09:13AM  Avanir Fetches $3.5B From Japan's Otsuka for Reformulated Cough Syrup at TheStreet
09:08AM  What We're Trading Yahoo Finance Blogs
08:25AM  Auto sales, and backing down in Hong Kong 5 things to know today at Fortune
08:10AM  AVANIR ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Avanir Pharmaceuticals, Inc. to Otsuka Pharmaceutical Business Wire
08:05AM  Japans Otsuka to buy U.S. drug maker Avanir for $3.5 billion at Fortune
07:54AM  Avanir Pharmaceuticals (AVNR) Stock Surges Today on $3.54 Billion Otsuka Deal at TheStreet
07:18AM  Wall St looks to car sales; Apple faces monopoly charge; Traditional retailers challenge online rivals Hot Stock Minute
07:12AM  Japans Otsuka to buy drug maker Avanir for $3.5 billion at MarketWatch
07:06AM  Otsuka to buy US drugmaker Avanir for $3.5B AP
07:04AM  Otsuka to buy US maker of promising Alzheimer drug at Financial Times
04:19AM  Avanir to be bought by Japan's Otsuka Pharmaceutical for $3.5 bln Reuters
03:52AM  Japans Otsuka Agrees to Buy Avanir Pharma For $3.5 Billion at Bloomberg
03:35AM  Avanir Pharmaceuticals To Be Acquired By Otsuka Pharmaceutical For $3.5 Billion PR Newswire
Dec-01-14 04:01PM  Avanir Pharmaceuticals Announces Date of Fiscal 2014 Fourth Quarter Financial Results and Conference Call GlobeNewswire
Nov-28-14 06:10AM  AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05:37AM  Will Avanir Pharmaceuticals (AVNR) Continue to Surge Higher? Zacks
Nov-27-14 10:50AM  Avanir's Migraine Drug Gets Complete Response Letter Zacks
Nov-26-14 06:13PM  Avanir to Provide More Human-Factor Data for Migraine Treatment at The Wall Street Journal
05:30PM  FDA rejects Avanir's migraine drug-device Reuters
04:54PM  Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA PR Newswire
Nov-24-14 07:14AM  DRJ: This is why I love options optionMONSTER
Nov-20-14 09:00AM  Avanir Pharmaceuticals to Participate in Two Conferences in December PR Newswire
Nov-12-14 04:48PM  AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
08:00AM  Avanir's AVP-825 Approval Could be Delayed (Revised) Zacks
Nov-10-14 04:40PM  Avanir Faces Regulatory Setback, AVP-825 Could Be Delayed Zacks
Nov-07-14 04:28PM  Another lackluster session for major equities Yahoo Finance Blogs
03:04PM  AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
12:35PM  Midday movers: Allergan, Freshpet, Transocean & more at CNBC
11:25AM  Avanir Pharmaceuticals (AVNR) Stock Drops After FDA Provides New Drug Application Feedback at TheStreet
08:30AM  Avanir Pharmaceuticals Announces Preliminary Feedback from the FDA on AVP-825 for the Acute Treatment of Migraine PR Newswire
Nov-04-14 08:52AM  Will Avanir Pharmaceuticals (AVNR) Stock React Today to This Analyst Action? at TheStreet
Oct-31-14 10:19AM  Perilous Reversal Stock: AVANIR Pharmaceuticals (AVNR) at TheStreet
Oct-30-14 04:01PM  Avanir Pharmaceuticals Announces Publication of Pivotal Phase III Results from AVP-825 Acute Migraine Study in the Journal "Headache" PR Newswire +6.54%
Oct-22-14 03:10PM  6 stocks to watch at MarketWatch
Oct-17-14 07:05AM  Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents at TheStreet
Oct-15-14 05:04PM  Concert Pharmaceuticals Announces Positive CTP-354 Data Zacks
Oct-14-14 05:05PM  Avanir (AVNR) Presents Detailed Phase II Data on AVP-923 Zacks
Oct-13-14 04:26PM  Avanir Pharmaceuticals Announces Presentation of AVP-923 Phase II Results in Agitation in Patients with Alzheimer's Disease at the American Neurological Association Meeting PR Newswire
Oct-08-14 04:15PM  Avanir Pharmaceuticals to Host Investor Briefing on October 15, 2014 PR Newswire
08:30AM  Avanir Pharmaceuticals Announces Data Presentations at the American Neurological Association's (ANA) 2014 Annual Meeting Including Results from the Phase II Trial for Treatment of Agitation in Patients with Alzheimer's Disease PR Newswire
Oct-01-14 06:49PM  Lightning Round: Manitowoc, Harman Int'l & more at CNBC
Sep-29-14 09:15AM  Avanir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares PR Newswire
Sep-25-14 03:09PM  AVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and EDGAR Online
Sep-24-14 11:06AM  Avanir Pharma prices $200M stock offering AP
10:10AM  How Will Public Offering Pricing Affect Avanir Pharmaceuticals (AVNR) Stock Today? at TheStreet
Sep-23-14 10:00PM  Avanir Pharmaceuticals Announces Pricing of Public Offering of Common Stock PR Newswire
03:13PM  Dow Down 0.6%; CarMax Shares Fall After Q2 Results Benzinga
11:20AM  Markets Mixed; Carnival Profit Tops Street View Benzinga
Sep-22-14 04:45PM  Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock PR Newswire
Sep-19-14 06:02PM  Nasdaq stocks posting largest percentage decreases AP -5.48%
06:59AM  Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% Zacks
Sep-18-14 03:46PM  4 stocks to watch at MarketWatch -6.49%
10:30AM  Insider Trading Alert - RSG, HAL And AVNR Traded By Insiders at TheStreet
08:25AM  The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead Zacks
Sep-16-14 04:44PM  Glimcher and Apple are big market movers AP
Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. It primarily offers NUEDEXTA, a dual N-methyl-D-aspartate receptor antagonist and sigma-1 agonist for the treatment of pseudobulbar affect; and Docosanol 10% cream, an over-the-counter product for the treatment of cold sores. The company's clinical development stage products comprise AVP-923, which has completed Phase II clinical trials for the treatment of central neuropathic pain in patients with multiple sclerosis; is in Phase II clinical trials for the treatment of agitation in patients with Alzheimer's disease; and is in Phase II clinical trials for the treatment of levodopa-induced-dyskinesia in Parkinson's disease, as well as completed Phase III trials for the treatment of patients with diabetic peripheral neuropathic pain. It is also developing AVP-786, a Phase I clinical trial novel investigational drug product for the treatment of neurologic and psychiatric disorders; and AVP-825, an investigational drug-device combination product, which is in Phase III clinical trials, to treat acute migraine. The company has a license agreement with Concert Pharmaceuticals, Inc. to develop and commercialize deuterium-modified dextromethorphan for the potential treatment of neurologic and psychiatric disorders, as well as rights to other deuterium-modified dextromethorphan compounds; and a license agreement with OptiNose AS for the development and commercialization of a novel breath powered intranasal delivery system to treat acute migraine. Avanir Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Aliso Viejo, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OCAMPO CHRISTINEVice President, FinanceDec 18Sale16.935,78097,855108,797Dec 18 08:55 PM
Katkin KeithPresident and CEODec 17Sale16.9362,5201,058,464914,249Dec 18 08:52 AM
OCAMPO CHRISTINEVice President, FinanceDec 16Option Exercise3.5230,000105,525144,577Dec 18 08:55 PM
OCAMPO CHRISTINEVice President, FinanceDec 16Sale16.9430,000508,200114,577Dec 18 08:55 PM
Katkin KeithPresident and CEODec 15Option Exercise1.61195,160314,3961,171,929Dec 18 08:52 AM
Katkin KeithPresident and CEODec 15Sale16.95215,1603,646,962976,769Dec 18 08:52 AM
PALEKAR ROHANSVP & Chief Commercial OfficerNov 28Sale15.0015,000225,000302,806Nov 28 09:00 PM
OCAMPO CHRISTINEVice President, FinanceOct 24Sale11.812,08024,56577,791Oct 24 08:22 PM
Siffert Joao MDSVP, R&DOct 24Sale11.808,42699,427222,554Oct 24 08:48 PM
OCAMPO CHRISTINEVice President, FinanceSep 15Sale9.4555,000519,75079,871Sep 17 08:44 PM
PALEKAR ROHANSVP & Chief Commercial OfficerSep 15Sale11.5025,000287,500266,750Sep 17 08:28 PM
OCAMPO CHRISTINEVice President, FinanceAug 26Sale6.102,11012,87179,871Aug 28 09:03 PM
Katkin KeithPresident and CEOAug 01Sale5.269,67050,864760,412Aug 01 08:44 PM
Katkin KeithPresident and CEOMay 28Sale5.01442,2122,215,482750,082May 30 08:00 PM
OCAMPO CHRISTINEVice President, FinanceMay 16Sale4.8811,90058,0723,000May 16 08:00 PM
OCAMPO CHRISTINEVice President, FinanceMay 14Sale5.1325,596131,30781,981May 16 08:00 PM